Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 23;1(2):91-8.
doi: 10.1016/j.celrep.2011.12.004. Epub 2012 Feb 2.

Long telomeres bypass the requirement for telomere maintenance in human tumorigenesis

Affiliations

Long telomeres bypass the requirement for telomere maintenance in human tumorigenesis

Michael A S Taboski et al. Cell Rep. .

Abstract

Despite the importance of telomere maintenance in cancer cell survival via the elongation of telomeres by telomerase reverse transcriptase (TERT) or alternative lengthening of telomeres (ALT), it had not been tested directly whether telomere maintenance is dispensable for human tumorigenesis. We engineered human tumor cells containing loxP-flanked hTERT to enable extensive telomere elongation prior to complete hTERT excision. Despite unabated telomere erosion, hTERT-excised cells formed tumors in mice and proliferated in vitro for up to 1 year. Telomerase reactivation or ALT was not observed, and the eventual loss of telomeric signal coincided with loss of tumorigenic potential and cell viability. Crisis was averted via the reintroduction of active but not inactive hTERT. Thus, telomere maintenance is dispensable for human tumorigenesis when telomere reserves are long. Yet, despite telomere instability and the presence of oncogenic RAS, human tumors remain susceptible to crisis induced by critically short telomeres.

PubMed Disclaimer

Figures

Figure 1
Figure 1. An hTERT-excisable tumorigenic cell line
(A) Western analysis of whole cell lysates (50 µg) from HA5, HT (HA5 + TERT) and HTR (HT + RAS) cells at indicated population doubling level (PDL). (B) RT-PCR analysis of hTERT, hph, and GAPDH at indicated PDL. (C) Analysis of telomerase activity of cell lysates (200, 100, 50 ng) at indicated PDL. LB, negative buffer control; CTL, HeLa cell lysate positive control; IC, internal control PCR product. (D) Replicative lifespan of HA5, HT and HTR cells. HT or HTR cells were immortal. (E) Anchorage-independent colony growth at indicated PDL (n=3). 293T cells were a positive control for colony formation. Statistical significance between HA5 (no colonies formed) and HT or HTR cell lines as indicated (n=3, *** p<0.001; ns, p>0.05, power(1-β err prob)>0.99, αactual=0.05, two-tailed). (F) TRF analysis of average telomere length at increasing PDL. 293T cells were included as a control. Weighted mean telomere lengths (kbp) are indicated below each lane. (G) Schematic of elements introduced into HA5 cells, at indicated PDL.
Figure 2
Figure 2. Excision of hTERT from tumor cells with short telomeres
(A) Western analysis of cell lysates (50 µg) in HTREP (Early Passage) cells transfected with Cre recombinase or empty vector control at indicated population doubling level (PDL). (B) RT-PCR analysis of hTERT, hph, and GAPDH at indicated PDL. (C) Replicative lifespan of indicated cell lines. HTREP Vec remained immortal. (D) Anchorage-independent colony formation at indicated PDL. 293T cells were included as a positive control, and HA5 as a negative control. HTREP Cre-4 at PDL 42 (no colonies) differed significantly from HTREP Cre-4 at PDL 8 (n=3, * p<0.05, power(1-β err prob)=1.0, αactual=0.05, two-tailed). (E) RT-PCR analysis of hTERT, Sh Ble (zeocin) and GAPDH in tissue extracted from renal capsule (RC) or subcutaneous (SC) injection sites, or normal adjacent kidney (NK). (F) TRF analysis of average telomere length at increasing PDL. Weighted mean telomere lengths (kbp) are indicated below each lane. (G) Schematic of elements introduced into HT cells, at indicated PDL. (H) Incidence of tumor formation of indicated cell lines in immunodeficient mice (see Experimental Procedures for details).
Figure 3
Figure 3. Excision of hTERT from tumorigenic cells with elongated telomeres
(A) Telomerase activity in cell lysates (200 ng) from HTRCre and HTRVec clonal cell lines at indicated PDL, controls as specified in Figure 2. (B) RT-PCR analysis of hTERT, hph, and GAPDH at indicated PDL. HA5 cells were included as a negative control. (C) Replicative lifespan of each clonal line, as indicated. HTRVec cells remained immortal. (D) Anchorage-independent colony growth at increasing PDL, including HA5 and HTR cells as controls (n=4 each), and 293T cells (n=3). Difference between the latest and earliest PDL within each line as indicated (**, p<0.01; ***, p<0.001, power(1-β err prob)=1.0, αactual=0.05, two-tailed). (E) TRF analysis of average telomere length at indicated PDL. Weighted mean telomere lengths (kbp) are indicated below each lane. (F) Analysis of telomere integrity. X-axis, individual lines and respective PDL; y-axis, average number of telomere signal-free ends (SFE) per metaphase (n=10). Brackets indicate a statistically significant difference (p<0.001, power(1-β err prob)=1.0, αactual=0.038–0.044). HTRVec at PDL 169 possessed no SFE. (G) Relative telomere length of the lines depicted in (F). X-axis, telomere fluorescence intensity in arbitrary units; y-axis, frequency of events. Early PDL (light grey), late PDL (dark grey). Graphs are scaled equivalently. (H) RT-PCR analysis of hTERT, Sh Ble (zeocin resistance) and GAPDH in normal adjacent kidney (NK) or renal capsule (RC). The water control (H2O) is the same as in Figure 2E, lane 11.
Figure 4
Figure 4. Ability of hTERT to rescue crisis in hTERT-excised cells
(A) Wild-type (WT) or mutant (Q169A; D868A, D869A) hTERT or empty vector (Vec) were introduced into HTREP Cre cells and analyzed for telomerase activity (200, 100, 50 ng lysate). (B) Replicative lifespan of cell lines as indicated above. hTERT WT cells remained immortal. (C) Anchorage-independent growth of cell lines as indicated (n=4). Statistical significance compared with vector controls as indicated (***, p<0.001, power(1-β err prob)=1.0, αactual=0.05, two-tailed). Controls and axis labels as in Figure 2.

Similar articles

Cited by

  • Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
    Shi J, Yang XR, Ballew B, Rotunno M, Calista D, Fargnoli MC, Ghiorzo P, Bressac-de Paillerets B, Nagore E, Avril MF, Caporaso NE, McMaster ML, Cullen M, Wang Z, Zhang X; NCI DCEG Cancer Sequencing Working Group; NCI DCEG Cancer Genomics Research Laboratory; French Familial Melanoma Study Group; Bruno W, Pastorino L, Queirolo P, Banuls-Roca J, Garcia-Casado Z, Vaysse A, Mohamdi H, Riazalhosseini Y, Foglio M, Jouenne F, Hua X, Hyland PL, Yin J, Vallabhaneni H, Chai W, Minghetti P, Pellegrini C, Ravichandran S, Eggermont A, Lathrop M, Peris K, Scarra GB, Landi G, Savage SA, Sampson JN, He J, Yeager M, Goldin LR, Demenais F, Chanock SJ, Tucker MA, Goldstein AM, Liu Y, Landi MT. Shi J, et al. Nat Genet. 2014 May;46(5):482-6. doi: 10.1038/ng.2941. Epub 2014 Mar 30. Nat Genet. 2014. PMID: 24686846 Free PMC article.
  • Dissecting Fission Yeast Shelterin Interactions via MICro-MS Links Disruption of Shelterin Bridge to Tumorigenesis.
    Liu J, Yu C, Hu X, Kim JK, Bierma JC, Jun HI, Rychnovsky SD, Huang L, Qiao F. Liu J, et al. Cell Rep. 2015 Sep 29;12(12):2169-80. doi: 10.1016/j.celrep.2015.08.043. Epub 2015 Sep 10. Cell Rep. 2015. PMID: 26365187 Free PMC article.
  • TINF2 is a haploinsufficient tumor suppressor that limits telomere length.
    Schmutz I, Mensenkamp AR, Takai KK, Haadsma M, Spruijt L, de Voer RM, Choo SS, Lorbeer FK, van Grinsven EJ, Hockemeyer D, Jongmans MC, de Lange T. Schmutz I, et al. Elife. 2020 Dec 1;9:e61235. doi: 10.7554/eLife.61235. Elife. 2020. PMID: 33258446 Free PMC article.
  • A yeast chemical genetic screen identifies inhibitors of human telomerase.
    Wong LH, Unciti-Broceta A, Spitzer M, White R, Tyers M, Harrington L. Wong LH, et al. Chem Biol. 2013 Mar 21;20(3):333-40. doi: 10.1016/j.chembiol.2012.12.008. Chem Biol. 2013. PMID: 23521791 Free PMC article.
  • Telomerase-Mediated Anti-Ageing Interventions.
    Dunn PL, Logeswaran D, Chen JJ. Dunn PL, et al. Subcell Biochem. 2024;107:1-20. doi: 10.1007/978-3-031-66768-8_1. Subcell Biochem. 2024. PMID: 39693017 Review.

References

    1. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA. 1992;89:10114–10118. - PMC - PubMed
    1. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349–352. - PubMed
    1. Capper R, Britt-Compton B, Tankimanova M, Rowson J, Letsolo B, Man S, Haughton M, Baird DM. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev. 2007;21:2495–2508. - PMC - PubMed
    1. Cascio SM. Novel strategies for immortalization of human hepatocytes. Artif. Organs. 2001;25:529–538. - PubMed
    1. Cesare AJ, Reddel RR. Alternative lengthening of telomeres: models, mechanisms and implications. Nat. Rev. Genet. 2010;11:319–330. - PubMed

Publication types

LinkOut - more resources